Search - tctmd.com

Displaying 241 - 260 of 1243

Sort: Relevancy | Date

News Conference News TCT 2023

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

Yael L. Maxwell

October 30, 2023

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

L.A. McKeown

October 27, 2023

News Conference News TCT 2023

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

Michael O'Riordan

October 26, 2023

News Conference News TCT 2023

CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER

Todd Neale

October 26, 2023

News Conference News TCT 2023

ALIGN-AR: Positive Results for Trilogy Valve in Aortic Regurgitation

Todd Neale

October 26, 2023

Presentation TCT 2023

TCT 444: Mid to Long-Term Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients with Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Presenter: Muhammad Adil Afzal

October 26, 2023

Presentation TCT 2023

TCT 218: Transcatheter Aortic Valve Replacement Versus Conservative Management in Patients with Low-flow Very Low-gradient Aortic Stenosis

Presenter: Lakshay Chopra

October 26, 2023

Presentation TCT 2023

TCT 121: Change in Pulmonary Artery Systolic Pressure after Transcatheter Aortic Valve Replacement in Patients with Low-flow Low-gradient Aortic Stenosis and its Prognostic Implications

Presenter: Lakshay Chopra

October 26, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

News Conference News TCT 2023

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Todd Neale

October 24, 2023

Presentation TCT 2023

Five-year Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial

Presenter: Rebecca Hahn

October 24, 2023

Presentation TCT 2023

Four-Year Outcomes From the EVOLUT Low Risk Trial

Presenter: Michael Reardon

October 24, 2023

Presentation TCT 2023

Mitral Transcatheter Edge-to-Edge Repair in Intermediate and Low-Risk Patients: Rationale, Evidence, and Ongoing Studies

Presenter: Gorav Ailawadi

October 24, 2023

Presentation TCT 2023

Five-Year Clinical and Echocardiographic Outcomes From The PARTNER 3 Low-Risk Randomized Trial

Presenter: Martin Leon

October 24, 2023

News Daily News

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

Yael L. Maxwell

October 20, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Conference News EACTS 2023

Extrathoracic Should Be Preferred Alternative to Transfemoral TAVI: Registry

Michael O'Riordan

October 11, 2023

News Conference News EACTS 2023

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

Michael O'Riordan

October 09, 2023

News Conference News EACTS 2023

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

Michael O'Riordan

October 05, 2023

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2023

Shelley Wood

October 03, 2023

Advertisement

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER

ALIGN-AR: Positive Results for Trilogy Valve in Aortic Regurgitation

TCT 444: Mid to Long-Term Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients with Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

TCT 218: Transcatheter Aortic Valve Replacement Versus Conservative Management in Patients with Low-flow Very Low-gradient Aortic Stenosis

TCT 121: Change in Pulmonary Artery Systolic Pressure after Transcatheter Aortic Valve Replacement in Patients with Low-flow Low-gradient Aortic Stenosis and its Prognostic Implications

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Five-year Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial

Four-Year Outcomes From the EVOLUT Low Risk Trial

Mitral Transcatheter Edge-to-Edge Repair in Intermediate and Low-Risk Patients: Rationale, Evidence, and Ongoing Studies

Five-Year Clinical and Echocardiographic Outcomes From The PARTNER 3 Low-Risk Randomized Trial

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

What’s Going to Be Hot at TCT 2023

Extrathoracic Should Be Preferred Alternative to Transfemoral TAVI: Registry

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

TCTMD’s Top 10 Most Popular Stories for September 2023

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content